Literature DB >> 7735126

New roles of low density lipoproteins and vitamin E in the pathogenesis of atherosclerosis.

N K Ozer1, D Boscoboinik, A Azzi.   

Abstract

Accumulation of oxidized low density lipoproteins in macrophages and smooth muscle cells causes foam cell formation, an initial step in atherosclerosis. Active oxygen species are considered important in the pathogenesis of the disease. Antioxidants, such as tocopherols and tocotrienols have been considered to prevent the deleterious effects of active oxygen species. We found native low density lipoproteins can stimulate directly smooth muscle cell proliferation, it is associated with an increase of protein kinase C activity. d-alpha-Tocopherol, biologically most active form of vitamin E, inhibits both cell proliferation and protein kinase C activity. The effect of d-alpha-tocopherol is not related to its radical scavenging properties. Transforming growth factor-beta secreted by smooth muscle cells as growth inhibitor. Low density lipoproteins decrease the release of transforming growth factor-beta from smooth muscle cells thus activating growth. d-alpha-Tocopherol activates the cellular release of transforming growth factor-beta. These new aspects explain the important role of low density lipoproteins and vitamin E in increasing and decreasing the risk of atherosclerosis, respectively.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7735126

Source DB:  PubMed          Journal:  Biochem Mol Biol Int        ISSN: 1039-9712


  6 in total

Review 1.  Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases.

Authors:  Bharat B Aggarwal; Chitra Sundaram; Seema Prasad; Ramaswamy Kannappan
Journal:  Biochem Pharmacol       Date:  2010-08-07       Impact factor: 5.858

2.  Inhibition of 2,2'-azobis(2,4-dimethylvaleronitrile)-induced lipid peroxidation by sesaminols.

Authors:  M H Kang; H Katsuzaki; T Osawa
Journal:  Lipids       Date:  1998-10       Impact factor: 1.880

3.  alpha-Tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state.

Authors:  R Ricciarelli; A Tasinato; S Clément; N K Ozer; D Boscoboinik; A Azzi
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

4.  Reduction in oxidative stress and modulation of heart failure subsequent to myocardial infarction in rats.

Authors:  Michael F Hill; Vince P Palace; Kuljeet Kaur; Dinender Kumar; Neelam Khaper; Pawan K Singal
Journal:  Exp Clin Cardiol       Date:  2005

5.  Association of serum levels of lipid and its novel constituents with the different stages of esophageal carcinoma.

Authors:  Yutao Diao; Hao Li; Huiqing Li; Yingzhi Zhou; Qing Ma; Yan Wang; Dong Li
Journal:  Lipids Health Dis       Date:  2009-10-29       Impact factor: 3.876

Review 6.  Oxidative stress, alpha-tocopherol therapy, and atherosclerosis.

Authors:  Andrea Harris; Sridevi Devaraj; Ishwarlal Jialal
Journal:  Curr Atheroscler Rep       Date:  2002-09       Impact factor: 5.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.